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                                                                 Abstract 
This study has examined the impact of health expenditure on health outcomes in the selected 
West African countries. The health outcomes used in this study are infant mortality, under-five 
mortality, and maternal mortality rates. A panel data set for 14 countries for the period 2000‒2018 was 
used. Aside from examining the role of total health expenditure on the health outcomes, we examine 
whether public and private healthcare expenditure could have dissimilar health outcomes. This 
research used  panel data estimation method. Panel data has some advantages over the cross sectional 
analysis and time series analysis in the sense that it controls for the effect of omitted variables, takes 
into consideration the international differences and provides more accura1te inference of model 
parameters via more degrees of freedom and more sample variability. A one percentage point increase 
in health expenditure will reduce infant mortality by 2.4 percent, under-five mortality by 3.9 percent 
and maternal mortality by 4.9 percent. These are economically significant effects too and indicate 
decent contribution of health resources toward building human capital in these economics. Human 
capital expansion presumably affects economic growth positively in the developing countries of West 
Africa, making it worthwhile to increase health expenditure in the region. 
 
 
 
 
 
 
 
                                                              Acknowledgment 
I thank the Almighty God for seeing me through the thick and thin of life. I sincerely want to 
appreciate my research mentor, Dr. Mukti Upadhyay, for his enormous support and supervision during 
the writing of this paper. More also, I register my gratitude to my thesis committee members, and Dr. 
Ali Moshtagh, Dr. Linda Ghent for their massive contribution in completing this research project. 
I thank my family members; Mr.& Mrs Baiyewu, Sola Kilanko, Damilola Kilanko, Segun 
Adeniran, Tunde Olawuni, Precious Allor, Aunty Bosede Woody, Uncle Onigbinde, Ayodele 
Alademomi, Aloba Oluwaseun for their moral and financial supports throughout my master’s degree 
program at EIU and my previous academic programs. 
 I sincerely express my gratitude to the Barber’s family for their profound kind gesture when I 
needed it most during my program. God bless you in return.  
To all immediate past and current graduate students in the department of Economics, I thank you all. 
 
 
 
 
 
 
 
 
 
 
 = 
Table of Contents 
CHAPTER ONE ...................................................................................................................................................... 5 
INTRODUCTION .................................................................................................................................................... 5 
1.1 Statement of the problem ......................................................................................................................... 7 
1.2 Objective of the study ................................................................................................................................ 8 
1.3 Hypothesis of the Study ............................................................................................................................. 9 
1.4 Organization of Study ................................................................................................................................ 9 
CHAPTER TWO ................................................................................................................................................... 10 
LITERATURE REVIEW .......................................................................................................................................... 10 
2.1 Empirical Studies ...................................................................................................................................... 10 
CHAPTER THREE ................................................................................................................................................. 21 
METHODOLOGY AND DATA ............................................................................................................................... 21 
3.1 The Model and Data ................................................................................................................................. 21 
3.2 Model specification .................................................................................................................................. 22 
3.3 Estimation techniques ............................................................................................................................. 24 
CHAPTER FOUR .................................................................................................................................................. 25 
DATA ANALYSIS AND INTREPRETATIONS ........................................................................................................... 25 
4.1   Descriptive Statistics .............................................................................................................................. 25 
Table 1: Descriptive Statistics .......................................................................................................... 26 
4.2 Trends in Health Expenditure .................................................................................................................. 26 
4.3 Trends in Health Outcomes ..................................................................................................................... 27 
4.4 Regression Results ................................................................................................................................... 30 
4.4.1 Results with Total Health Expenditure on the health outcomes ................................................. 31 
Table 2: Effects of Total Health Expenditure on Mortality Rates ......................................................... 31 
4.4.2   Results with Decomposed Health Expenditure per Capita ................................................................. 34 
CHAPTER FIVE .................................................................................................................................................... 37 
CONCLUSION AND POLICY IMPLICATIONS ......................................................................................................... 37 
 
                                                 CHAPTER ONE 
                                               INTRODUCTION 
 
Over the years, economic theory has identified human capital as an important impulse to 
economic growth in all facets of life. Before the introduction of human capital theory, growth theory 
only considered physical capital as the most important input into the output produced. But after the 
introduction of human capital theory in the 1960s, health and education of the labor force were 
recognized as essential inputs in production. For human capital to spur growth, healthy time is required 
for both market and non-market activities. Health care financing becomes vital in producing healthy 
time or sustaining human capital. To achieve development, a fair amount is expected to be spent on 
the health care sector of the economy. Health care financing that will be discussed in this work will be 
the total expenditure as well as the components, government and private expenditure. Effects of health 
care financing can be measured in terms of the health outcomes such as infant mortality, under-five 
mortality, maternal mortality and life expectancy.  Population health is affected by many factors such 
as social and economic conditions. 
 A country is said to have effective health system if the health status and outcomes of the citizen 
is better than that of a similar country with similar health care resources. Rates of infant, under-five, 
and maternal mortality are important health outcomes on which lies the focus of this research. Infant 
mortality rate measures how many infants (less than one year of age) die per 1000 live births in a given 
year. Infant mortality consists of neonatal and post-neonatal mortality rate. The neonatal mortality rate 
indicates deaths that occur in the first four weeks of life and this is usually caused by problems during 
pregnancy such as congenital abnormalities, low birth weight and also problems during delivery such 
as birth injuries and asphyxia and after delivery such as measles and other infections. Post-neonatal 
mortality rate is related to maternal and obstetric factors such as poverty, inadequate health care, 
infectious diseases and injuries (UNICEF, 2011). 
Under five mortality rate is the chance that a child will die between birth and exactly five years of age 
per 1000 live births. The major causes of this death is diarrhea, malaria, tetanus, pneumonia and other 
infections. Most of these illnesses are caused by poverty, civil conflict and malnutrition and these are 
common in Western Africa, which is part of the sub-Saharan Africa. 
Maternal mortality rate is the expectation that a female will die because of childbirth. This is measured 
as the number of female deaths per 100000 live births from any cause related to pregnancy and its 
management. Death from pregnancy is not less than half a million per year and these deaths occur 
mostly in developing nations (WHO, 2004) and this is more a result of a lack of access to emergency 
care, inadequate health care and family planning procedure. According to UNICEF (2009) the causes 
of maternal mortality can be direct or indirect. Direct causes can be obstetric complications such as 
postpartum hemorrhage, eclampsia and complications of abortion. Iodine deficiency during pregnancy, 
anemia, malaria and even HIV/AIDS are the causes of indirect death in mothers. The underlying causes 
includes inadequate maternal care, lack of knowledge and information, malnutrition and dirty 
environment. 
Infant, under-five, and maternal mortality rate is a very big issue especially in developing 
countries and this has attracted the attention of various stakeholders and researchers. This is because 
there is a belief that unhealthy infants and children grow up to become sickly adults who form the labor 
force of the economy and a weak labor will definitely create a vicious cycle of low productivity, weak 
economic growth and development and this will in turn worse population health status. The burden of 
mortality and morbidity among the poor is widely regarded as one of the public health concerns in the 
world today and has become a major issue in the international community and this was reflected in the 
millennium development goals and now in the sustainable development goals of the 2030 Agenda for 
sustainable development. 
Mostly, UNICEF and World Bank have incorporated child mortality reduction into their future 
programs. According to UNICEF, about 29,000 children under the age of five die every day, which 
means an average of 21 per minute, mainly from preventable causes. These deaths occur mostly in 
developing countries like Nigeria. Some of these deaths are from preventable causes such as malaria, 
tetanus, or measles. The importance of health economics cannot be over-emphasized and this is 
because health in childhood is one of the key predictors of productivity in later life. 
Health outcomes in developed countries have been improving along with health expenditure. 
According to (OECD, 2012) the infant mortality rate has dropped more than tenfold and the life 
expectancy have increased over fifty years by about ten years. Over the same period, the health 
expenditure share of the gross domestic product rose from 3 percent to about 10 percent.   
1.1 Statement of the problem 
 
UNICEF (2011) shows 11 million infants under the age of one die each year and 90% of such 
death occurs in developing countries including many in West Africa, the focus of this study. Although 
under-5 mortality has been declining, yet at the end of the last decade these deaths were still as high 
as seven million. (UNICEF 2012). Infant and under-five mortality is often caused by diseases such as 
malaria, pneumonia as well as other infections. These diseases are mostly influenced by poverty, 
malnutrition and war. A majority of maternal mortality rate, the number of female deaths per 100000 
live births, occurs in the developing economies as well, caused primarily by inadequate health care and 
family planning (WHO, 2004).  
Most studies on health care expenditure and health outcomes have been on developed 
economies. For developing countries, research on this topic based on sound data has been few and far 
between. Paucity of data on developing countries has been one of the main reasons. This study focuses 
on health expenditure by both public and private sectors and relates it to mortality outcomes in selected 
14 West African countries. Infants and children that are unhealthy grow into sickly adults and this in 
turn creates a vicious cycle of low productivity, weak economic development and poor standards of 
living. On the maternal side, women who die during childbirth leave a trail of unhappy life and poverty 
for the rest of the families.  
How strong is the relationship of total and component health expenditures with health outcomes 
in West African countries? Is private spending more effective in reducing mortality than public 
spending on health? By addressing these questions, this research can generate some useful policy 
implications for developing countries in general and the sample West African countries in particular.  
Development of a relevant model for analyzing the health sector outcomes is critical. This 
research critically reviews the literature to formulate an appropriate model which will explore our key 
questions by including a set of control variables to make our estimates as unbiased and consistent as 
possible.  
1.2 Objective of the study  
 
The objective of the study is to analyze the impact of health care expenditure on health 
outcomes in selected West Africa countries using panel regression analysis. We will also disaggregate 
the expenditure into public and private and see how these expenditures affect   the health outcomes 
using annual data from 2000 to 2018.  
1.3 Hypothesis of the Study 
 
The general hypothesis of the study is that health expenditure has significant impact on the health 
outcomes. For testing purpose, the following null and alternate hypotheses are stated 
Hypothesis 1:  
H0 :  Total expenditure is positively related to the reduction of infant, under-five, and maternal mortality 
rates 
H1 : :  Total expenditure has  impact in reducing infant, under-five, and maternal mortality rates 
Hypothesis 2:  
H0 : Government expenditure has much more of an impact on mortality reduction than the impact of 
expenditure by the private sector. 
H1: Government expenditure has a significantly less of an impact on mortality reduction than an equal 
expenditure by the private sector. 
1.4 Organization of Study 
This study spans five chapters. After this introductory chapter, Chapter two presents literature 
review which is followed by Chapter three for a conceptual framework based on theories and empirical 
reviews of previous studies relevant to this study. Data presentation and econometric analysis, 
estimation and interpretation of results will be presented in Chapter four. The last chapter summarizes 
the findings in brief and offers conclusions and policy recommendations 
 
 
 
                                              CHAPTER TWO 
                                        LITERATURE REVIEW 
 
2.1 Empirical Studies 
The rich are more likely to have access to good health care without support from the 
government. The poor are significantly less healthy. Spending on health care is therefore important for 
health outcomes of the poor who cannot easily afford access to health care unless heavily subsidized. 
Hence poor households are more likely to benefit from a government provided health care than from 
out-of-pocket private facilities (Gwatkin, 2000). It is the public health care financing in developing 
countries that can bridge the gap between the health status of the poor and the rich. 
There have been many studies on the topic of health care financing and health outcomes that 
tend to reveal how health financing minimizes the poor-rich differences in health outcomes. The 
empirical evidence on this topic is mixed, some study supports the fact that health expenditure reduces 
mortality rate and increases life expectancy, while others reveal a positive relationship of expenditure 
with mortalities. Some studies find mixed results. 
Gani (2008) discusses the relationship between per capita public health expenditure and three 
measures of health outcomes. The study uses cross-ountry data from seven pacific island countries 
between 1990 and 2002. The fixed-effects estimation procedure was adopted for the study to control 
for the country-specific factors. Gani (2008) finds government health care finance affects infant 
mortality rate more than under five mortality. The outcome is consistent with the government 
budgetary allocation to health care in the Pacific Island countries, which are largely targeted for 
primary health care services such as immunization, control of diarrhea, nutritional training for mothers 
and some antenatal care. 
Dhrifi (2018) investigated the effects of health expenditure on child mortality rates using a 
simultaneous-equation model for 93 developed and developing countries with data spanning from 1995 
to 2013. He analyzes the relationship for developed and developing economies by comparing low, 
lower middle, upper-middle and high-income countries. The study employed the three-stage least 
squares (3SLS) technique to be able to solve the endogeneity problems by introducing instrumental 
variables. Results show that the explanatory variables differ according to the sample considered. 
Government health spending has a positive and very significant effect in reducing mortality rates for 
upper-middle and high-income countries buts for low and lower-middle income countries, government 
health expenditure is not statistically significant. Higher health expenditure was found in the developed 
economies and low health spending in less developed economies. The insignificant spending in the 
less developed countries according to this study may indicate resources not being allocated effectively 
towards health care spending. The study also shows that in less developed countries, public expenditure 
on health has a greater effect on mortality rates than private health expenditure, while in developed 
countries private expenditure has a positive impact on child health status. 
Rahman et al. (2018) investigate the relationship between different types of health care 
expenditure (total, public and private) and the three main health care outcomes (life expectancy at 
birth, crude death rate and infant mortality rate) in the region of South Asian Association for Regional 
Cooperation (SAARC) and the Association for South East Asian Nations (ASEAN). Using the World 
Bank data set for 15 countries over the period of 1995 to 2014, a panel data analysis was conducted. 
Based on the findings, the total health expenditure has a significant effect in reducing infant mortality 
rate in the region. The separate effects of the private and public health care expenditure were examined 
and as expected, they were both negative and significant which implies that both types of health care 
expenditure are necessary for improving the overall health in these countries. Private health care 
expenditure significantly reduced the crude death rate in the region, while public health spending 
showed the opposite result. This may be due to the improper utilization of public sector funds. The 
study did not find any significant effect of healthcare on life expectancy. 
Cre´mieux et al.’s (1999) study examines the relationship between health care spending and 
health outcomes in Canada. Canadians’ social, environment and consumption conditions were 
considered as part of the control variables. Despite very small differences in per capita health care 
spending and health outcomes across provinces, a strong relationship exists. It was deduced from the 
model that lower the health care spending in Canada, the lower the life expectancies and higher infant 
mortality rates. A 10% reduction in health care expenditure is associated with infant mortality rates 
going higher by 0.5% among males and 0.4% among females, and life expectancies lower by 6 months 
for men and 3 months for women. Even though differences in health care expenditure levels across 
Canadian provinces are not that much, health care expenditure remain the main determinant of health 
outcomes. Furthermore, supply side variables, such as health care spending or the number of available 
physicians, are also highly significant determinants of health outcomes even after controlling for socio-
economic factors.  
Novignon et al. (2012) study Sub-Saharan Africa to understand the impact of health care 
expenditure on health status. Health status is measured by life expectancy at birth, crude death rate and 
infant mortality rate. The results show that health care expenditure was associated with increase in life 
expectancy and reduction in infant mortality rates. Even though both private and public sources of 
health care expenditure were significantly associated with improved health outcomes, public health 
care expenditure had relatively larger impact. The study suggests a greater need for regional 
governments to increase allocation of resources to health care service delivery.  Effective public-
private partnerships in developing the health sector could improve health status of the population in 
general. 
Raeesi et al (2018) provided econometric evidence of a link between health expenditures and 
three health outcomes (infant mortality, under 5 mortality and life expectancy) within four different 
health care systems. Panel data were collected and grouped for 25 countries according to the health 
care system over a period of 15years (2000-2015). The countries included in the study based on their 
different health care systems. The study classified the health systems into 4 different categories such 
as National Health Insurance System, Traditional Sickness Insurance, National Health Services, mixed 
systems. Multivariate regression model was used to investigate the effects of studied variables on 
health. The results showed that among various explanatory variables, health expenditure (public and 
private) had important effect on health outcomes. Based on the classification of countries with different 
health care systems, increase in the health expenditure also has a significant impact on improving 
health outcomes. The study concluded that, based on the different impacts of private and public health 
expenditure on health outcomes in each health care system, public sector should be more responsible 
in countries with National Health Service. In countries with mixed system, however, the private sector 
should be more responsible for the health care of the country. 
Using panel data, Anyanwu and Erhijakpor (2009) find support for the argument that total and 
government expenditure on health matter for health outcomes. The study examined the relationship 
between total as well as government health expenditure on health outcomes (infant mortality and 
U5MR) using data from 47 African countries between the period of 1990 to 2004. Based on the results, 
the public health spending as well as the total expenditure on health are crucial to health outcomes 
because health expenditure have a statistically significant effect on infant mortality and under-five 
mortality. 
Nixon and Usman (2006) examine the relationship between health care expenditure and health 
outcomes in countries of the EU over the period 1980-1995, using life expectancy (female and male) 
and infant mortality as the dependent variables. Econometric analyses were conducted on a panel data 
set for the former 15 members of the European Union over the period. The results from the study reveal 
that increasing health expenditure are notably associated with large improvements in infant mortality 
but only marginally associated to life expectancy. It was noted that females have gained marginally 
more than males. This study went ahead to see the relationship in health expenditure and health 
outcomes between developed and developing countries and came out with the fact that there is a 
positive marginal effect of health expenditure on the examined health outcomes for developed 
countries, but more so for infant mortality than life expectancy. This was consistent with diminishing 
returns in the area of health care in developed nations. On the contrary, small health care spending in 
developing countries and even intermediate nations, have certainly bigger impact. 
Syeda et al. (2013) investigate the linkage between health care expenditures (HCE), economic 
growth and health outcomes (i.e., life expectancy (LE), infant mortality and the share of elderly people) 
on South Asian Association for Regional Cooperation (SAARC) countries over the period of 1995–
2010. Panel co-integration technique is used for analysis of short and long run relationship between 
the health care expenditures and health outcomes. The results show that there is a long-run relationship 
between health expenditures, economic growth and health outcomes in SAARC region.  Life 
expectancy and share of elderly people in population have a negative relationship related to health care 
expenditures. This implies that health care expenditures are not necessity but rather luxury goods in 
SAARC countries. On the other hand, there exists no significant relationship between infant mortality 
and health expenditures. According to Syeda et al. (2013), SAARC countries import 80% of all medical 
devices and equipment, 30% public hospitals cater to 80% of the population, public hospital buildings 
are poorly maintained, and are equipped with poorly functioning and outdated equipment. World’s 
largest populated countries, more pollution, poor life style and so on lead the SAARC nations on 
declined pathway and unachieved goals are still dreamt by nation. This means that health care 
expenditures donnot translate to reduction in infant mortality. In the same vein, health care 
expenditures have not helped to improve the growth of these nations in the SAARC region. The study 
then suggested that there is a need for sufficient rationalizing of the budget allocation practices in 
health sector.  Provision of incentives to work in remote locations should be a priority and such reforms 
and strategies should be planned and implemented so as to be able to achieve the desired result of 
improving the health status of the SAARC countries, and particularly Nepalese people through more 
equitable and efficient resource allocation. In the era of globalization and modern technological world, 
this region needs to meet and compete for international health standards by improving poor health 
system infrastructure to maintenance level, poverty conversion to equality, and malnutrition to balance 
diet. 
Tae and Shannon (2013) also empirically examined the relationship between public health 
expenditure and national health outcomes but they did so for developed countries. Data was collected 
from 17 OECD countries between 1973 and 2000. Two health outcome indicators were used for the 
study, namely: infant mortality rate and life expectancy at birth. To analyze cross-country panel data, 
a mixed-effect model was used. Based on the results, there exists statistically significant association 
between government health expenditure and public health outcomes. Particularly, the findings showed 
that a negative relationship exists between government health expenditure and infant mortality rate, 
and a positive relationship between government health expenditure and life expectancy at birth. This 
result implies that a higher level of public health expenditure significantly decreases infant mortality 
and increases life expectancy, controlling for other socio-economic conditions in the given countries. 
The results also reveal that public health expenditure is a very strong predictor for health outcomes. 
This study suggested that there should be increased government spending on medical goods and 
services in order to provide better overall good health for individuals.  
Bhalotra (2007)’s research is on India for 28 years, 1970-1998. The study examined the 
relationship between state health expenditure and infant mortality. His main contribution was to exploit 
sub-national panel data on health care expenditure to identify how it affected infant mortality. Based 
on the result, the author finds that the state health expenditure saves no lives but upon allowing lagged 
effects, controlling for trended unobservable and restricting the sample to rural households, a 
significant effect of health expenditure on infant mortality emerged. This study concluded that there 
are striking differences in the impact of state health expenditure by social group. 
Novignon and Lawanson (2017) sought to understand the relationship between the child health 
outcomes and health spending. The study employed panel data from 45 sub-Saharan African countries 
over the period 1995 -2011. Aside from the fact that the paper studied the relationship between the two 
main variables, the study went ahead and investigated the lagged effect of health care spending. This 
study also carried out a disaggregated analysis of the health spending into private and public spending 
in relation to the child health outcomes, which are infant mortality, under-five and neonatal mortality. 
The results of the study indicate that health expenditure had significant and positive influence on child 
health outcomes in Sub-Saharan African nations with elasticities of -0.11 for infant mortality, -0.15 
under-five mortality and -0.08 neonatal mortality. From the analysis, there also exists a positive and 
significant lagged effect of health expenditure on child health. On the disaggregated level, public health 
expenditure was found to be more significant than private expenditure. 
Farag et al. (2013) studied relationships for 1995, 2000, 2005, and 2006 in a panel data setting 
to examine the relationship between country health expenditure, selected health outcomes which are 
infant mortality and under-five mortality and government effectiveness. Government effectiveness 
was included in the analysis to investigate if good governance improves the effectiveness of 
government health spending. This paper collected data from 133 low and middle-income countries 
for ensuring a large sample size. A fixed effects model was employed to control for time-invariant 
country-specific unobservable determinants of health outcomes. The results from the study indicated 
that income matters, but that health care spending is also an important determinant of health outcomes. 
The paper observed clearly that there exist beneficial effects of macro-level health spending on health 
outcomes if the right policies and institutions accompany it. 
Eric et al. (2017) investigates the relationship between healthcare expenditures and health 
outcomes (i.e. infant mortality, under-5 mortality and life expectancy) from 1995 to 2014 in Ghana. 
Ghana’s healthcare expenditure has been on the increase for the past two decades. Increasing 
healthcare expenditures is expected to enhance the acquisition of better hospital resources that will 
improve healthcare. From the results, infant and under-5 mortalities declined by 50 and 25%, 
respectively, as of 2014, while life expectancy increased from 60.7 to 64.8 years. Out-of-pocket 
payments on health care decline but are higher than the World Health Organization’s recommended 
financial threshold. While government’s expenditure on healthcare have yielded positive results, the 
improvement in the health outcomes is not attributable to the increasing health expenditure alone.  
This paper explains the policies on maternal health, national health insurance and healthcare reforms 
that have influenced health outcomes. The study also highlights the challenges of healthcare system 
in Ghana of which the major ones are inadequate financial investments in health, and limited health 
workforce and facilities. This work recommended that there is the need to establish new health 
institutions and expand existing ones, government should provide incentives to health workers, the 
concept of predictive, preventive and personalized medicine (PPPM) for treating NCDs should be 
introduced, and lastly, alternative insurance schemes should be designed for vulnerable groups. 
Finally, there must be willingness of the government to curb misappropriation of funds, to achieve 
better health outcomes. 
Akinci et al (2014) examine the impact of health care expenditures on health outcomes on 19 
countries in the Middle East and North Africa (MENA) region. Panel data collected between the 
periods 1990-2010 was used to estimate impact of the independent variable on the dependent variable. 
The health expenditure was disaggregated into both public and private spending and the health 
outcomes into three categories namely infant, under-five and maternal mortality rates. According to 
the results, the average infant mortality rate declined from 42.2 deaths per 1000 live births in 1990-
1995 to 24.7 in 2006-2010. Child mortality rate in the region has been reduced from 54.4 deaths per 
1000 live births in 1990-1995 to 30.2 deaths per 1000 live birth, while in this period the average 
maternal mortality rate declined from 134.6 deaths per 100000 births to 71.1. Concisely, after 
controlling for confounding factors, both government and private spending on health care 
significantly improve infant, under-five, and maternal mortality in the MENA region. 
Rad et al. (2013) compare the effect of public and private expenditure on health status in 
Eastern Mediterranean Countries. The health status indicator that is used in this study is infant 
mortality rate. The health expenditure was divided into public and private in order to ascertain the 
relationship that exists between the types of expenditure and health status. The data used for this study 
was between 1995 and 2010. Public health expenditures contain social security spending, taxing to 
private and public sectors, and foreign resources like loans and subventions. On the other hand, private 
health expenditures contain out of pocket expenditures and private insurances. The model was 
estimated using the random effects and the results showed that public health expenditure had a strong 
negative relationship with infant mortality rate. However, surprisingly a positive relationship was 
found between the private health expenditures and infant mortality rate (IMR). The relationship for 
public health expenditures was significant, but for private health expenditures, it was not. Each of 
these has different effects on the health status. The study findings showed that the public health 
expenditures in the EMR countries impacts health outcome positively, while the private health 
expenditures did not have any significant relationship with health status, so often increasing the public 
health expenditures leads to reduce IMR. However, this relationship was not significant because of 
contradictory effects for poor and wealthy peoples. 
Yaqub et al (2012) examines how governance in Nigeria affects the effectiveness of public 
health expenditure. They investigate the impact of public health spending on infant and under-5 
mortalities as well as life expectancy Data on public health expenditure and governance variable 
captured by the corruption perception index were regressed on infant mortality, under-five mortality 
and life expectancy, using the ordinary least squares and the two-stage least squares. According to 
this paper, public policy is expected to promote good health in the economy, so that broad based 
economic growth can be achieved and the more reason why many countries devote huge budgetary 
allocation to health, but in most developing countries especially, this huge health expenditure failed 
to translate into better health status. The result obtained from the study show that public health 
expenditure has a negative effect on infant mortality and under-5 mortalities when the governance 
indicators are included. This means that to achieve the Millennium development goal of lowering 
infant mortality by two-thirds by 2015, reducing under-5 mortality rate and raising life expectancy in 
Nigeria were projected to be unattainable if the level of corruption was not reduced considerably. As 
the level of corruption goes down and value of the corruption perception index rises, health status 
improves drastically, and there is a decline in infant and under-5 mortalities and life expectancy rises. 
This implies that for public expenditure on health to lead to improvement in health status, the issue 
of corruption must be addressed.  
 
The health outcomes in this work are all centered on mortality rate (infant, under-five and 
maternal) in West Africa. Compared with developed countries, life expectancy is lower and mortality 
rates are higher in developing countries. Many deaths result from infectious diseases such as malaria, 
but also from measles, tuberculosis, polio, and diphtheria. Although its incidence has been falling, 
women also die due to complications arising from HIV/AIDS. Most of these diseases are not self-
manifestation in nature but are the result of the other risk factors such as risk of unsafe sex, unsafe 
drinking water, malnutrition and even exposure to indoor smoke.  
West Africa has struggled to raise the low quality of its health care delivery in both public and 
private sectors. Among a host of reasons for such an outcome is a lack of adequate medical personnel, 
especially in the rural areas (Chaundhury, Hammer, Kremer, Muralidharan, and Rogers, 2006). 
Medical personnel in this region often leave their nations in search of greener pasture. Most of the 
countries that are unable to provide public health care to their citizenry are often not able to regulate 
private sector’s quack practices, which often contribute to higher child and maternal mortality as well. 
The literature reviewed above does not conclusively show a clear relationship between healthcare 
expenditures and health outcomes.  
 
                                                         
                                                      CHAPTER THREE 
                               METHODOLOGY AND DATA 
This study will employ dataset from World Development Indicator Databank.This provides the necessary data 
required for this study. However, this study will make do with the selected countries in West Africa based on  
availability of data. In examining the relationship; and controlling for variables such as poverty (captured by 
 consumption expenditure), health care expenditure which under the total analysis will be health expenditure as  
a percentage of gross domestic product and under the disaggregated analysis into public health expenditure 
 per capita and private health expenditure per capita, malaria, urbanization and foreign aid against the 
 dependent variables, which are infant mortality, under five mortality and maternal mortality rate. 
3.1 THE MODEL AND DATA  
The econometric approach that will be used in this study will be panel data regression in 
equations for infant, under-five and maternal mortality rates. The specification is elated to existing 
literature and it allows for ways through which health expenditure can affect the chosen health 
outcomes in the selected 14 West African countries.  
Thus, dependent variables used in the model are 
Infant mortality (death between birth and age 1 per 1000 live births) 
Under-five mortality (probability of death by age 5 per 1000 live births) 
Maternal mortality (per 100000 live births) 
 
 
Independent and control variables used are: 
Health expenditure as a percentage of gross domestic product 
Per capita public health expenditure for disaggregated analysis 
Per capita private health expenditure for disaggregated analysis 
Poverty proxy by per capita household consumption 
Gross domestic product 
Malaria (incidence of malaria) 
Urbanization (as a percentage of the total population) 
Foreign Aid (net official development aid) per capita 
3.2 Model specification  
Yit = f (Hit,Wit )  
Where Yit is the health outcomes (infant mortality, or under 5 mortality or maternal mortality rate),  
Hit is total health expenditure and 
Wit is a vector of social-economic control variables.  
In a reduced form, the Specification above can be rewritten as  
Yit  = α + βI ln ( ConsGdpit) + β2 ln ( hegit) + β3 ln (gdp it) + β4 ln (mal it) + β5ln ( urbanpopit) + β6 ln ( 
odacap it).  
Where Yit   Health outcomes (infant mortality or maternal mortality rate)  
ConsGdp it = per capital household consumption expenditure is used to proxy poverty level 
 Hegit = health expenditure as a percentage of gross domestic product and per capital for the 
disaggregated analysis 
GDPit = GDP per capita in US dollars  
 Urbanpop it = urban population as a measure of urbanization  
Malit = incidence of malaria  
 Odacapit = foreign Aids 
The aproiri expectation of the study based on literature reviewed is that most of the coefficients (βI, β2, 
β3, β5, β6) should be negative while β4 (the effect of malaria) should be positive. 
 Health expenditure, both total and disaggregated (public and private), is an inflow of fund into 
health and this is expected to have a negative effect on infant mortality, under 5 mortality, and maternal 
mortality rates. This means that an increase in the health expenditure is expected to broaden the access 
to health care and services, which helps to decrease these mortality rates. Increasing health expenditure 
should improve the health status of the population and foster economic growth and development. 
Demographic factors, such as urban population, can help in understanding any difference in 
health situation across sectors. Based on previous studies, mortality rate is higher among rural, low-
income households than among the urban households. This is because of, among other reasons, the 
access to better health facilities in the metropolitan areas or cities. Private cost of health such as 
transportation may also be lower for urban households because of proximity. So based on facts, it is 
expected that urbanization will have a negative relationship with the health outcomes in this study.  
The per capita income is a proxy for socio economic status in general. Gupta et al. (1999) 
concluded in their study that as per capita income rises, population health status improves and this 
implies that increase in income have a high tendency to reduce infant and maternal mortality rates. The 
impact of income on health works through many indirect channels because higher income also leads 
to better nutrition, and the ability to pay for health care and services, better education and better 
sanitation.  
Incidence of malaria is one of the major sicknesses that are peculiar to African nations. This 
sickness is capable of killing if not treated and monitored properly. This is expected to increase the 
rate of mortality both in infants and in women.   
3.3 Estimation techniques  
Literature shows different estimation techniques and methods that have been used to analyze 
the relationship between healthcare expenditure and health outcomes. Examples are cross-sectional 
analysis, autoregressive distributed lag model, and panel data technique. This research will be using 
panel data estimation method. Panel data has some advantages over the cross sectional analysis and 
time series analysis in the sense that it controls for the effect of omitted variables, takes into 
consideration the international differences and provides more accurate inference of model parameters 
via more degrees of freedom and more sample variability.  
  
                                                      CHAPTER FOUR 
                           DATA ANALYSIS AND INTREPRETATIONS 
 4.1   Descriptive Statistics 
This section presents descriptive statistics of the various variables used in the model. The data 
covers a sample of 14 West African countries ranging from 2000 to 2018. The table 1 below presents 
some relevant statistics.  The average infant mortality rate (deaths per 1000 live births) for these 
countries is about 70.1 with a standard deviation of about 24.5. Over the period, Cape Verde recorded 
the lowest infant mortality rate of 15 in 2017, with Sierra Leone recording the highest value of 142 in 
2000.  Under five mortality rates averaged 113 with a standard deviation of 454 over the period.  The 
lowest value is 17.4, recorded by Cape Verde in 2017, while the highest value of 233.1 was recorded 
by Sierra Leone in 2000.  Maternal mortality rate also averaged 680.9 with a standard deviation of 423  
Cape Verde again records the lowest Value of 42 in 2015 while the highest value of 2650 again 
recorded by Sierra Leone in 2000. Household consumption expenditure per capita also averaged 741.5 
with a standard deviation of 475.1.  Sierra Leone again recorded the lowest value of 208.1 in 2000 and 
the highest value of 2450.1 was recorded again by Cape Verde.  Health expenditure as a percentage of 
GDP averaged about 5.47% over the period with a standard deviation of 2.5. The lowest value of 
2.143% recorded by Nigeria in 2002. The highest value of 20.415 % is recorded by Sierra Leone in 
2015. Health expenditure is further decomposed into public and private health expenditure. The data 
used is in per capita. Government health expenditure relatively lower average value of 14.15, compared 
to 24.071 for private expenditure.  Malaria prevalence averaged 294.3 per 1000 of the population at 
risk with a standard deviation of 155.6. The highest value of 607.1 was recorded by Burkina Faso in 
2000 and the lowest value of 0.01 was for Cape Verde in 2012. Sierra Leone’s performance was 
generally the worst by most measures of health care mainly because of the politically unstable 
environment.  
                                         Table 1: Descriptive Statistics 
Variable  Obs Mean  Std. Dev Min Max 
imr 252 70.125 24..539 15 142 
u5m 252 112.959 44.823 17.4 233.1 
mmr 224 680.959 427.8714 42 2650 
ConsGdp 218 741.461 475.082 208.206 2450.089 
HlthExGr 238 5.4703 2.524 2.143 20.415 
Gdpcap 252 929.416 762.633 139.315 3670.429 
Malaria 126 294.284 155.548 0.01 607.11 
Uubanpop 252 40.007 11.005 16.186 65.261 
GovHExCap 238 14.146 21.322 1.175 108.946 
PvtHExCap 238 24.071 15.084 3.471 79.832 
Odacap 252 78.982 94.079 1.337 650.857 
 
 
Net development assistance received per capita also averaged $78.98 with a standard deviation 
of 94.08. This shows a larger dispersion in ODA to sub Saharan Africa. Cape Verde records the highest 
ODA per capita of   $650.857 in 2010.  The lowest value of $1.337 is recorded by Nigeria in 2001.                          
4.2 Trends in Health Expenditure 
 
The graph in Figure 1 shows the trends in health expenditure growth for all the countries in the 
sample.  All countries show fluctuating growth in health expenditure over the period. Countries such 
as Burkina Faso, Liberia, Guinea and Togo have experienced generally upward trends.  Benin Cote 
D’lvoire, Mali, Ghana and others have experienced a general decline in health expenditure after 2002.  
These trends show an unstable health expenditure pattern. This instability could have implications on 
health outcomes in the region. This may also have a spillover on the growth and development of the 
nations. 
          Figure 1: Health Expenditure Growth in West Africa 
 
4.3 Trends in Health Outcomes 
The graphs Figure 2 to Figure 4 below show the trends in the various health outcomes used in 
this study.  Infant mortality rate and under five mortality rates have experienced similarly downward 
trends in all the countries over the period. The graphs for the two mortality rates look similar because 
of the high correlation between these two variables. The improvements in health conditions reflect the 
recent surge in health interventions in the region.  Compared to global estimates, however, West Africa 
still falls short, with most countries still having maternal mortality, under five mortality and infant 
mortality rates higher than world threshold levels.  
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 Figure 2: Trend of Infant Mortality in West Africa 
   
 
 
 
Figure 3: Trend of Under - five Mortality Rate in West Africa 
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 Figure 4: Trend of Maternal Mortality Rate in West Africa 
   
4.4 Regression Results 
The short time series of data we have for each country and a relatively small group of countries 
that comprise West Africa make a panel data model ideal for estimating the relationship of health 
outcomes with health expenditures. We estimate fixed and random effects models to determine which 
model is appropriate for our data. Three health outcome variables (the mortality rates) are used in the 
estimations. Each regression relates a health outcome with three measures of health expenditure 
growth: total, public, and private. The Hausman test can tell us which of the models is most appropriate 
and suitable. That model is then run with robust standard errors to control for the possibility of 
heteroscedasticity and autocorrelation.   
The results of all regressions and relevant Hausman tests are provided in the appendix. The final 
regressions with the robust standard errors are presented and interpreted below. 
4
0
04
5
05
0
0 5
5
06
0
0
m
m
r
2000 2005 2010 2015 2020
year
Benin
3
5
04
0
04
5
05
0
0 5
5
0
m
m
r
2000 2005 2010 2015 2020
year
Burkina Faso
4
05
06
07
08
0
m
m
r
2000 2005 2010 2015 2020
year
Carbo Verde
6
4
0
6
6
0
6
8
0 7
0
0
7
2
0
7
4
0
m
m
r
2000 2005 2010 2015 2020
year
Cote D'lvoire
3
0
0 3
5
04
0
04
5
05
0
0
m
m
r
2000 2005 2010 2015 2020
year
Ghana
7
0
08
0
09
0
01
0
0
0
m
m
r
2000 2005 2010 2015 2020
year
Guniea
6
0
08
0
0
1
0
0
0
1
2
0
0
1
4
0
0
m
m
r
2000 2005 2010 2015 2020
year
Liberia
6
0
0
6
5
0
7
0
0
7
5
0
8
0
0
8
5
0
m
m
r
2000 2005 2010 2015 2020
year
Mali
6
0
0 6
5
07
0
07
5
08
0
0
m
m
r
2000 2005 2010 2015 2020
year
Mauritania
5
5
06
0
0 6
5
0
7
0
07
5
08
0
0
m
m
r
2000 2005 2010 2015 2020
year
Niger
8
0
09
0
0
1
0
0
0
1
1
0
0
1
2
0
0
m
m
r
2000 2005 2010 2015 2020
year
Nigeria
3
0
0 3
5
04
0
04
5
05
0
0
m
m
r
2000 2005 2010 2015 2020
year
Senegal
1
0
0
0
1
5
0
0
2
0
0
0
2
5
0
0
3
0
0
0
m
m
r
2000 2005 2010 2015 2020
year
Sierra Leone
3
5
04
0
04
5
05
0
0
m
m
r
2000 2005 2010 2015 2020
year
Togo
Maternal Mortality Rate
4.4.1 Results with Total Health Expenditure on the health outcomes 
Tables 2, 3, and 4 report the results of three regressions each ‒ for the three mortality rates 
(under-5, infant, and maternal). Each regression was initially run in both fixed effects (FE) and random 
effects (RE) specifications and the Hausman test was conducted to determine the best specification. 
RE produces unbiased estimates and produce small standard errors if the omitted country-specific 
characteristics are uncorrelated with the explanatory variables. FE, on the other hand, directly controls 
for the unobserved omitted characteristics which are correlated with the variables included in the 
model. This makes FE consistent whereas RE is more efficient if it turns out to be consistent as well. 
The Hausman test actually rejects the consistency of the RE models in our data and leads to the 
desirability of FE in all cases. These results are displayed on Table 10 in the appendix. The fixed effects 
results with robust standard errors are presented and interpreted below in Tables 2 through 4. 
 
 
 
 
 
 
 
Table 2: Effects of Total Health Expenditure on Mortality Rates 
 (1) (2) (3) 
VARIABLES u5m Imr Mmr 
ConsGdp 0.0788 -0.149 0.326 
 (0.315) (0.159) (2.546) 
HlthExGDP -4.379** -1.673** -33.05*** 
 (2.165) (0.608) (5.609) 
Gdpcap -0.0167* -0.00188 -0.0430 
 (0.00953) (0.00339) (0.0455) 
Malaria 0.0396 0.0245 -0.257 
 (0.0384) (0.0204) (0.201) 
Urbanpop -2.508** -2.939*** -21.95*** 
 (1.233) (0.707) (7.079) 
Aidcap -0.0411 -0.0357* -0.385 
 (0.0497) (0.0196) (0.244) 
Constant 234.3*** 204.8*** 1,861*** 
 (53.74) (27.14) (234.7) 
Observations 111 111 97 
R-squared 0.596 0.717 0.438 
Number of countries 14 14 14 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
  
The results show a negative effect of health expenditure as a percentage of GDP (HlthExGDP) 
on health outcomes.  Column (1) of Table 2 shows that for a one-percentage point increase in health 
expenditure as a percentage of GDP, under-five mortality decreases by 4.4 points, ceteris paribus1. 
This is significant at the 5% level. In addition, infant mortality rate falls by 1.7 points, in response to 
a percentage point increase in health expenditure growth. Maternal mortality drops by 33 points (or a 
fall of 0.33 in maternal death per 1000 live births) for a one percentage point increase in health 
expenditure.  This is highly significant at the 1% level.  Around the mean values of mortality, a one 
percentage point increase in total health expenditure reduces under-5 mortality by 3.9 percent, infant 
mortality by 2.4 percent, and maternal mortality by 4.9 percent. Thus, irrespective of the health 
outcome adopted, increased health expenditure significantly improves health outcomes.  
Household consumption expenditure (ConsGdp) which proxies for poverty is found to have a 
positive relation with under-five mortality and maternal mortality, and a negative relation with infant 
mortality. The coefficients are, however, statistically insignificant in all models.  Another variable, 
GDP per capita, is negatively related with health outcomes as expected. However, only the effect on 
under five mortality is statistically significant, at 10%. Other variables held constant, a $100 increase 
in GDP per capita results in a 1.7 fewer under-5 deaths per 1000 live births, indicating a small economic 
significance of GDP per capita, once health expenditure and other variables have been controlled for.  
West Africa is a relatively malaria-prone zone but with a large difference of malaria prevalence 
across countries (between 0 and 607 per 1000 of the population at risk )  for Cape Verde and Burkina 
Faso respectively). Would a higher incidence of malaria lead to more deaths? The variable’s coefficient 
is not, however, statistically significant. Next, with respect to urbanization, the expectation was that 
 
1 In other words 44 fewer children would die per 10,000 live births. (Mortality rate is deaths per 1000 live births.) 
greater urbanization with better health facilities in cities and towns would help lower all types of 
mortality. Our data support this hypothesis as the coefficients are highly significant. Urbanization, 
which is simply urban population as a percentage of total population, reduces mortality at varying 
rates. Around the respective means, a one percentage point increase in urbanization lowers under-5 
mortality by 2.2 percent, infant mortality by 4.2 percent, and maternal mortality by 3.2 percent. These 
are fairly sizeable effects.  
Development assistance, or foreign aid received, per capita (Aidcap) also has a negative effect 
on health outcomes as expected. However, only the coefficient for infant mortality rate is significant. 
A $100 increase in ODA per capita leads to 3.6 fewer deaths of infants, or a 5 percent reduction at the 
mean value.  
The overall fitness of the models, depicted by the within R-squared, shows that about 59.6% 
of the variation in under five mortality is explained by the independent variables specified in the model. 
This value is about 71.7% for infant mortality and 43.8% for maternal mortality respectively. 
4.4.2   Results with Decomposed Health Expenditure per Capita  
  The correlation between public and private health expenditures is 0.37, this means that the two 
variables are not high correlated and  there is no issue of collinearity. This section presents results for 
the models that decompose health expenditure into expenditures incurred by government and the 
private sector.  Similarly, separate regressions are run for under five mortality, infant mortality and 
maternal mortality rate.  These results with their corresponding Hausman tests are presented as 
regression 4, 5 and 6 respectively. The Hausman tests lead to the fixed effects results in all cases.  
Hence the fixed effects with robust standard errors results are presented and interpreted below: 
   
Table 3 
Results with Decomposition of Health Expenditure into Public and Private 
 (1) (2) (3) 
VARIABLES U5M IMR MMR 
    
ConsGdp 0.214 -0.0607 2.156 
 (0.459) (0.219) (4.849) 
GovHGdp 0.278 0.204 2.158 
 (0.317) (0.141) (1.519) 
PvtHGdp -1.331* -0.593** -12.34 
 (0.662) (0.265) (10.03) 
Gdpcap 0.0251* 0.0100 0.215 
 (0.0131) (0.00597) (0.201) 
Malaria 0.0417 0.0332 -0.119 
 (0.0476) (0.0192) (0.131) 
Urbanpop -6.468*** -3.106*** -23.81*** 
 (1.659) (0.671) (4.991) 
Odacap -0.0966** -0.0427* -0.456 
 (0.0419) (0.0216) (0.272) 
Constant 354.4*** 194.0*** 1,611*** 
 (72.94) (31.37) (289.5) 
Observations 111 111 97 
R-squared 0.667 0.741 0.509 
Number of countries 14 14 14 
Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
A striking result in Table 3 is that government health expenditures (GovHGdp) do not provide 
significant effects on any of the three mortality outcomes whereas private expenditures affect infant 
and U-5 mortality significantly. Even the sign of the government expenditure’s coefficient is 
unexpectedly positive. On the other hand, the a priori expectation of a negative relationship with 
mortality comes out true for private expenditure (PvtHGdp). Looking at the mean value of private 
health expenditure across countries ($24.1, higher than public health expenditure) a dollar increase in 
domestic private health expenditure results in a 1.331 reduction in under five-mortality rate and a 0.593 
reduction in infant mortality rate. It can be inferred that private health expenditure has a much more 
significant effect on health outcomes than government health expenditure.  This result is somewhat 
surprising and calls for reallocation of health resources between public and private sectors. 
Urbanization remains highly significant in economic as well as statistical sense. The 
coefficients are comparatively larger as well than those in the previous specifications. Other variables 
held constant, a one-percentage point increase in urban population results, per 1000 live births, in 6.5 
fewer deaths of children under five, 3.1 fewer infant deaths, and 2.4 fewer maternal deaths. All of these 
effects are significant at 1% level.  Foreign aid received per capita has a negative effect on health 
outcomes as expected. A $10 increase in aid results in a one fewer death of children under five, and a 
0.4 reduction in infant mortality. The coefficient for maternal mortality is statistically insignificant.  
Other variables look similar in their effects to those in the specification for total health 
expenditure. Surprisingly, however, GDP per capita now has a positive relationship with under-five 
mortality, albeit at 10% level. As expected, malaria prevalence displays a positive relationship with 
infant and under-5 mortality though the effect is not significant. 
The overall fit of the three mortality regressions with component health expenditures is better 
than for models with total expenditure as judged by the within R-squared.  
                                                CHAPTER FIVE 
                CONCLUSION AND POLICY IMPLICATIONS 
 
 
This study has examined the impact of health expenditure on health outcomes in the selected 
West African countries. The health outcomes used in this study are infant mortality, under-five 
mortality, and maternal mortality rates. A panel data set for 14 countries for the period 2000‒2018 was 
used. Aside from examining the role of total health expenditure on the health outcomes, we examine 
whether public and private healthcare expenditure could have dissimilar health outcomes. The control 
variables used for this work are poverty (proxy by household consumption expenditure), gross 
domestic product, urbanization, the incidence of malaria, and foreign aid. 
The general hypothesis for this study was that an increase in health expenditure would reduce 
mortality rates of infants, children under five, and mothers. Our panel data indicate that health 
expenditure is, as expected, negatively related to health outcomes. A one percentage point increase in 
health expenditure will reduce infant mortality by 2.4 percent, under-five mortality by 3.9 percent and 
maternal mortality by 4.9 percent. These are economically significant effects too and indicate decent 
contribution of health resources toward building human capital in these economics. Human capital 
expansion presumably affects economic growth positively in the developing countries of West Africa, 
making it worthwhile to increase health expenditure in the region. 
 
GDP’s effect conforms to the a priori expectation for under five mortality although it is not 
significant for infant or maternal mortality rate. This implies that GDP’s effect differs across different 
outcomes. This result again emphasizes the need to be wary of interpreting higher GDP growth rates 
in Sub-Saharan Africa as an indication of general improvement in living conditions.  
 The expected positive correlation of the incidence of malaria with all types of mortality, 
however, turned out statistically insignificant. Urbanization, on the other hand, provides a noticeably 
powerful impact on health outcomes. Urbanization enables access to good roads, faster emergency 
responses, and greater concentration of professionals and health centers. The facilities generally lead 
to improved health service delivery. A clear policy implication is that an improvement in urban 
infrastructure leads to better health outcomes. A greater focus on urban health infrastructure should 
not, however, be made at the cost of rural development, as this will only exacerbate the already wide 
health inequalities existing in the region.  
It is not surprising that foreign aid conforms to the a priori expectation in terms of its 
contribution to a reduction of infant and under-5 mortality. This is because much of the time foreign 
aid is directed towards developing or strengthening preventive health care system including 
immunization against polio, measles, tetanus, tuberculosis and hepatitis B, among others.  
Based on the disaggregated analysis, our findings reveal that public and private health 
expenditure have different effects on the health outcomes. Government health expenditure was found 
to be positively related to all the health outcomes but it does not exert a significant impact. On the 
other hand, private health expenditure reduces mortality of all types studied, and also provides a 
significant impact on infant and under five mortalities though not a significant impact on maternal 
mortality. This may be because of how public health funds are used in these countries. Public health 
system in many developing countries is characterized by misallocation, overspending due to corruption 
and delays due to lack of good governance. Private health expenditure is more significant in improving 
health outcomes than public expenditure. This is in line with the findings of Novignon et al. (2017) 
that the effect of public health spending is less than the effect of private health spending. Because of 
public goods aspect of large infrastructure, public health expenditure is expected to be more significant 
in developing regions such as Sub-Saharan Africa. Our results, however, call for a reassessment of 
public-private emphasis on health expenditures in the region.  
Based on the findings of this study, there should be an increase in the funds allocated to 
healthcare in West Africa in order to ensure adequate facilities and funds for improved health care 
delivery. This means that money spent on health will improve the health condition of the people 
thereby causing the nation to have a healthy labor force and this can transform to economic growth 
and development 
Steps should be taken to reduce the various bottlenecks that hinder the proper disbursement of 
funds for health purposes. The administrative and political issues such as corruption should be checked 
to ensure quick and efficient allocation. 
 Public-private partnership may go a long way to help the region to improve the health status 
of the population at large. Steps should also be taken make private health more affordable.  This could 
be done through effective health insurance programs that subsidize private health care which could 
greatly improve healthcare accessibility.  
This study faced a major issue with data availability which limited the rigor of the analysis.  It 
is possible to cover more countries and data to further examine the findings of this paper. More health 
outcome variables can also be used.  A consistent measure of inequality such as the Gini coefficient 
can be used to see whether inequality of income can explain a part of health outcome. It is possible 
that endogeneity in health expenditure could be a concern since the size of health resources may depend 
on economic growth. These issues could be explored and addressed possibly  by using methods such 
as the two-stage least squares.  Also, depending on data availability, time series econometric techniques 
can be used on country specific basis. This will allow for an individual assessment of the situation for 
each country and for assessing any dynamic relationships that may exist.  
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   Appendices  
   Table 4: Regression 1 
 Fixed  
effects 
Random 
Effects 
 
VARIABLES u5m 
 
u5m 
 
   
ConsGdp -0.00600 0.0247 
 (0.229) (0.0182) 
heg -3.495** -4.023*** 
 (1.454) (1.105) 
gdpcap -0.00263 -0.0247*** 
 (0.00754) (0.00841) 
mal 0.0229 0.0727** 
 (0.0358) (0.0322) 
urbanpop -6.223*** -2.221*** 
 (0.969) (0.648) 
odacap -0.0832** -0.0212 
 (0.0378) (0.0315) 
Constant 382.4*** 202.6*** 
 (42.35) (29.08) 
   
Observations 111 107 
R-squared 0.638  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
  Table 5: Regression 2 
 Fixed  
Effects 
Random 
Effects 
VARIABLES mri mri 
   
ConsGdp -0.149 0.00814 
 (0.0977) (0.00968) 
heg -1.673*** -2.181*** 
 (0.620) (0.574) 
gdpcap -0.00188 -0.0119*** 
 (0.00322) (0.00433) 
mal 0.0245 0.0408** 
 (0.0153) (0.0170) 
urbanpop -2.939*** -1.077*** 
 (0.414) (0.352) 
odacap -0.0357** -0.0147 
 (0.0162) (0.0163) 
   
Constant 204.8*** 116.7*** 
 (18.07) (15.79) 
   
Observations 111 107 
R-squared 0.717  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
 
 Table 6: Regression 3 
 Fixed 
Effects 
Random 
Effects 
VARIABLES mmr mmr 
   
hcecap -0.252 -0.110 
 (0.197) (0.180) 
heg -30.64*** -19.56* 
 (10.02) (10.52) 
gdpcap 0.0120 -0.104 
 (0.0863) (0.0816) 
mal -0.0307 0.0996 
 (0.316) (0.322) 
urbanpop -21.26*** -5.030 
 (7.772) (6.780) 
odacap -0.477 -0.428 
 (0.309) (0.319) 
Constant 1,926*** 1,162*** 
 (322.0) (299.2) 
   
Observations 93 93 
R-squared 0.464  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
 
    
Table 7: Regression 4 
 Fixed  
Effects 
Random 
Effects 
VARIABLES u5m u5m 
   
hcecap -0.00419 0.0245 
 (0.0178) (0.0196) 
dgep 0.219 -0.235 
 (0.307) (0.305) 
dpep -1.005*** -0.801*** 
 (0.216) (0.292) 
gdpcap 0.0220*** -0.00595 
 (0.00796) (0.0112) 
mal 0.0980*** 0.0897*** 
 (0.0261) (0.0332) 
urbanpop -6.325*** -1.606** 
 (0.631) (0.645) 
odacap -0.0856*** -0.0376 
 (0.0245) (0.0352) 
Constant 345.3*** 156.8*** 
 (27.01) (28.81) 
   
Observations 107 107 
R-squared 0.809  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
 
 Table 8: Regression 5 
 Fixed 
Effects 
Random 
Effects 
VARIABLES mri mri 
   
hcecap -0.00208 0.00853 
 (0.00881) (0.0108) 
dgep 0.177 -0.196 
 (0.151) (0.168) 
dpep -0.579*** -0.342** 
 (0.107) (0.162) 
gdpcap 0.0116*** -0.00506 
 (0.00393) (0.00620) 
mal 0.0528*** 0.0536*** 
 (0.0129) (0.0182) 
urbanpop -3.019*** -0.264 
 (0.311) (0.351) 
odacap -0.0429*** -0.0189 
 (0.0121) (0.0195) 
Constant 179.9*** 72.16*** 
 (13.32) (15.68) 
   
Observations 107 107 
R-squared 0.813  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
 
         Table 9 : Regression 6 
 Fixed 
Effects 
Random 
Effects 
VARIABLES mmr Mmr 
   
Hcecap -0.156 -0.0995 
 (0.207) (0.176) 
Dgep 0.606 -2.646 
 (4.056) (2.964) 
Dpep -10.52*** -7.738*** 
 (2.460) (2.512) 
Gdpcap 0.232** 0.0881 
 (0.0922) (0.0969) 
Mal 0.225 0.217 
 (0.294) (0.312) 
Urbanpop -22.70*** -5.773 
 (7.781) (6.950) 
Odacap -0.471 -0.476 
 (0.299) (0.299) 
Constant 1,709*** 1,099*** 
 (310.7) (298.3) 
   
Observations 93 93 
R-squared 0.523  
Number of country 14 14 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
  
               Table: 
10: Hausman 
Test results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                  Hausman Tests 
Regression Hausman Test 
coefficient 
P- Value Decision 
1 41.99 0.000 Fixed Effects 
2 17.97 0.003 Fixed Effects 
3 31.10 0.000 Fixed Effects 
4 579.42 0.000 Fixed Effects 
5 2049.91 0.000 Fixed Effects 
6 15.47 0.030 Fixed Effects 
  
 
 
 
 
 
